The Atopic Dermatitis Control Tool, A High-Performance Tool for Optimal Support
The evaluation of global atopic dermatitis control is key to minimizing the disease burden. The Atopic Dermatitis Control Tool (ADCT) has been developed for this purpose. Participants [diagnosed by a physician] were recruited using a real-life methodology and asked to answer a questionnaire to provide sociodemographic and personal information. The ADCT algorithm described by Pariser was used to categorize patients as having controlled or uncontrolled atopic dermatitis. Data were collected on 1606 patients. The patients’ median age was 40 quartiles [31, 42.45] years, and 1,023 (63.7%) patients were women. A total of 1,146 (71.4%) patients did not have controlled atopic dermatitis according to the ADCT score. Patients with uncontrolled disease were at a significantly higher risk of a high stress level and had more opportunities to miss work than patients with controlled disease. In this study, we showed that a key factor for predicting the disease burden is patient self-assessed disease control in terms of multiple dimensions: stress, sleep, quality of life, work absenteeism and loss of productivity.